Healthcare Professional Confirmation

The information on the page you are about to enter is intended for Healthcare Professionals only.

By ticking the box below, you confirm that you are a Healthcare Professional.

Submit Return to the Patient Website
The UroLift System Icon

The UroLift® System

An early alternative to medical therapy that provides rapid relief and recovery of BPH symptoms.1,3,4 The UroLift® System is minimally invasive and offers better symptom relief than medication4 with a lower risk profile than TURP.2

Learn More About the Procedure

Clinical Results Icon

Results

The UroLift System is supported by extensive clinical experience in controlled studies; large multi-centre studies; small studies; retrospective registry and peer-reviewed publications. 

Explore the Results

Publications

Publications

View the spectrum of UroLift System clinical results and data:

  • Meta-Analyses
  • Real World Experience Studies
  • Clinical Studies 
  • International Publications
  • Reviews

View More Publications

IFU Icon

Instructions for Use

Download the UroLift System Instructions for Use document to learn more about:

  • Product Description
  • Device Positioning (Lateral and Median Lobes)
  • Implant Deployment
  • MRI Safety Information

See Instructions for Use

Source Information

  1. Shore, Can J Urol 2014
  2. Sonksen, Eur Urol 2015
  3. Roehrborn, J Urology 2013
  4. Roehrborn, Can J Urol, 2017

Indicated for the treatment of symptoms of an enlarged prostate up to 100cc in men 45 years or older. As with any medical procedure, individual results may vary. Most common side effects are temporary and include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence (Roehrborn, J Urology 2013). Rare side effects, including bleeding and infection, may lead to a serious outcome and may require intervention. Consult the Instructions for Use (IFU) for more information.

Contraindicated in men with current gross hematuria, urinary tract infection, urinary incontinence, urethral conditions that prevent device insertion, or a prostate volume greater than 100cc.

Teleflex, the Teleflex logo, UroLift, the UroLift logo, BPH Advisor, MyBPHReport, and UroLift ATC are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the US and/or other countries.

Grosvenor House Horseshoe Crescent

Old Town Beaconsfield

HP9 1LJ

© 2025 Teleflex Inc. All rights reserved.    |    Terms of Use   |    Internet Privacy Policy   |   Patient Safety   |   Imprint   |   Compliance
MCI-2022-0108